HOME >> BIOLOGY >> NEWS
JCI table of contents: April 12, 2007

EDITOR'S PICK: Two heads are better than one: two dysfunctional DNA repair pathways kill tumor cells

Individuals who inherit two mutant copies of any one of about 12 genes that make the proteins of the Fanconi Anemia (FA) pathway develop FA, which is characterized by increased incidence of cancer and bone marrow failure, among other things. However, individuals with just a single mutant copy of one of these genes are also at increased risk of developing cancer. This occurs when the remaining "good" copy of the gene becomes mutated in a specific cell type, allowing that cell type to form a tumor. However, hope of a new treatment for these cancers has now been provided by researchers from the Dana-Farber Cancer Institute in Boston who suggest that inhibiting the protein ATM might kill these cancer cells.

In the study, which appears online on April 12 in advance of publication in the May print issue of the Journal of Clinical Investigation, Alan D'Andrea and colleagues show that loss of ATM function in human cell lines with a dysfunctional FA pathway caused the cells to die. The dying cells were characterized by high levels of DNA breakage, which is consistent with the fact that FA pathway proteins and ATM are important regulators of two distinct DNA repair pathways. It therefore seems that the ATM pathway of DNA repair keeps the FA pathwaydeficient tumor cells alive and that loss of this pathway results in tumor cell death. As FA pathwaydeficient tumor cells were shown to be sensitive to an inhibitor of ATM, the authors suggest that ATM might provide a therapeutic target for the treatment of individuals with FA pathwaydeficient tumors.

TITLE: Fanconi anemia pathwaydeficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated

AUTHOR CONTACT:
Alan D. D'Andrea
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Phone: (617) 632-2112; Fax: (617) 63
'"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
12-Apr-2007


Page: 1 2 3 4 5 6

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... November 14, 2018 , ... uBiome, the leader in ... director of Flatiron Functional Medicine to its Medical Advisory Board. Joining the board ... to uBiome extensive experience in treating the root causes of disease, conscientiously taking ...
(Date:11/14/2018)... ... November 14, 2018 , ... In recognition of World ... raise diabetes awareness and advocacy. The company is reaching out to help educate patients ... as emphasize the importance of vision testing for people with the disease. , The ...
(Date:11/13/2018)... ... November 13, 2018 , ... ... are a class of MS instrumentation with capability to resolve complex sample ... Specifically, those coupled to liquid chromatograph (HRAM LC/MS) have been used extensively ...
Breaking Biology News(10 mins):
(Date:11/13/2018)... ... 13, 2018 , ... , Park Systems, world leader in Atomic Force Microscopes ... demand for AFM technology in China, Park Systems has decided to provide direct support ... Beijing equipped with Park AFM. , The Grand Opening of the Park Beijing Office ...
(Date:11/9/2018)... JACKSONVILLE, Fla. (PRWEB) , ... November 08, 2018 ... ... companies in the United States, adopted a machine-learning powered approach to increasing recovery ... was centered around an Artificially Intelligent Collections (AIC) product developed by NLP Logix, ...
(Date:11/6/2018)... TAHOE, Nev. (PRWEB) , ... November 06, 2018 ... ... their native mobile app for clinical trial data collection and management. TrialKit ... iPhone users with compatible generation devices can quickly and easily sign in to ...
(Date:11/5/2018)... ... 05, 2018 , ... 2Blades has completed a non-exclusive license ... code technology for applications in advancing research in epigenetic technology. , 2Blades ... in 2009, the efficacy of TAL effector-based DNA targeting has been established rapidly ...
Breaking Biology Technology:
Cached News: